Sign in
SGHT Stock Price, Chart, Stats & News
Sight Sciences, Inc.
Save
279.12M
Market cap
–
Current P/E
–
Forward P/E
SGHT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 86.17% |
Operating margin | -47.96% |
Pretax margin | -49.66% |
Net margin | -49.67% |
Effective tax rate | -0.03% |
ROA | -33.33% |
ROE | -55.72% |
D/E | 0.64x |
Interest coverage ratio | -7.22x |
SGHT valuation
P/E | – |
P/S | 2.71x |
P/B | 3.22x |
P/CF | -6.94x |
P/FCF | -7.00x |
P/OCF | -6.94x |
PEG | -0.32x |
EV multiple | -7.12x |
About
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED).
Similar securities
Based on sector and market capitalization
Report issue